About Texas Epilepsy Group
Clinical Trials at Texas Epilepsy Group
During the past decade, Texas Epilepsy Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Texas Epilepsy Group
According to Clinical.Site data, the most researched conditions in "Texas Epilepsy Group" are
"Drug Resistant Partial Onset Seizure" (2 trials). Many other conditions were trialed in "Texas Epilepsy Group" in a lesser frequency.
Clinical Trials Intervention Types at Texas Epilepsy Group
Most popular intervention types in "Texas Epilepsy Group" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ganaxolone" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Epilepsy Group
The vast majority of trials in "Texas Epilepsy Group" are
2 trials for "All" genders.
Clinical Trials Status at Texas Epilepsy Group
Currently, there are NaN active trials in "Texas Epilepsy Group".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Texas Epilepsy Group,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Epilepsy Group, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".